References
- 1 Global skin disease morbidity and mortality an update from the Global Burden of Disease Study 2013. JAMA Dermatol. 153(5), 406–412 (2017).
- 2 Global Burden of Disease Study Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386(9995), 743–800 (2015).
- 3 Union for Ethical BioTrade. A review of patent activity in the cosmetics sector in the context of the ethical sourcing of biodiversity. Patents, plants and countries of origin. IUCN (ID: MON-084309) (2010). www.ecolex.org/details/literature/a-review-of-patent-activity-in-the-cosmetics-sector-in-the-context-of-the-ethical-sourcing-of-biodiversity-patents-plants-and-countries-of-origin-mon-084309/.
- 4 Chromone: a valid scaffold in medicinal chemistry. Chem. Rev. 114(9), 4960–4992 (2014).
- 5 Chromone as a privileged scaffold in drug discovery: recent advances. J. Med. Chem. 60(19), 7941–7957 (2017).
- 6 Chemistry of Heterocyclic Compounds: Chromenes, Chromanones, and Chromones. Ellis GP (Ed.). John Wiley & Sons, Inc. (2008).
- 7 Chromones as a privileged scaffold in drug discovery: a review. Eur. J. Med. Chem. 78, 340–374 (2014).
- 8 Novel benzopyran derivatives and their therapeutic applications: a patent review (2009–2016). Expert Opin. Ther. Pat. 27(9), 1031–1045 (2017).
- 9 Synthesis and pharmacological activities of non-flavonoid chromones: a patent review (from 2005 to 2015). Expert Opin. Ther. Pat. 25(11), 1285–1304 (2015).
- 10 . Plant stem cells in cosmetics: current trends and future directions. Future Sci. OA 3(4), FSO226 (2017).
- 11 Restorsea, LLC: US8992996B2 (2015).
- 12 A tomato stem cell extract containing antioxidant compounds and metal chelating factors protects skin cells from heavy metal-induced damages. Int. J. Cosmet. Sci. 33(6), 543–552 (2011).
- 13 . Review plant cell cultures as source of cosmetic active ingredients. Cosmetics 1(2), 94–104 (2014).
- 14 Park Young OH: KR101800788B1 (2017).
- 15 Elang Co Ltd: KR20160135569A (2016).
- 16 Merck Patent GmbH: WO128562 (2006).
- 17 Kyushin Pharmaceutical Co Ltd: JP2017088571A (2017).